TSOI OTC
Therapeutic Solutions International, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$99K
-52.1% ▼
5Y CAGR: +95.3%
Gross Profit
$62K
-51.1% ▼
5Y CAGR: +115.9%
Operating Income
-$2M
+39.4% ▲
Net Income
-$2M
+43.1% ▲
EPS (Diluted)
$-0.00
+53.3% ▲
EBITDA
-$1M
+50.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $27K | $63K | $146K | $207K | $99K |
| YoY Growth | +689.2% | +128.0% | +132.9% | +41.7% | -52.1% |
| Cost of Revenue | $3K | $13K | $43K | $79K | $37K |
| Gross Profit | $24K | $50K | $103K | $127K | $62K |
| Gross Margin | 89.0% | 79.6% | 70.9% | 61.6% | 62.9% |
| R&D Expenses | $28K | $562K | $795K | $1M | $561K |
| SG&A Expenses | $1M | $1M | $2M | $2M | $1M |
| Operating Expenses | $1M | $2M | $2M | $3M | $2M |
| Operating Income | -$1M | -$2M | -$2M | -$3M | -$2M |
| Operating Margin | -3794.0% | -2950.8% | -1578.8% | -1586.0% | -2006.7% |
| Interest Expense | $351K | $302K | $612K | $646K | $423K |
| Income Before Tax | -$2M | -$2M | -$3M | -$4M | -$2M |
| Tax Expense | $0 | $0 | $800 | $2K | $2K |
| Net Income | -$2M | -$2M | -$3M | -$4M | -$2M |
| Net Margin | -6173.2% | -3509.7% | -2029.0% | -1844.6% | -2191.9% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$1M | -$2M | -$2M | -$3M | -$1M |
| Shares Outstanding | 1.28B | 1.91B | 2.26B | 2.53B | 3.17B |